Associate Professor Georgina Long has won the InStyle Women In Style Award
14 May 2015
Associate Professor Georgina Long of Melanoma Institute Australia (MIA) has won the InStyle Women In Style Awards for the Science and Environment category. Dr Long was nominated by InStyle over 6 months ago and since then there has been a public voting campaign as well as selection by a very high-powered influential panel of women including Jana Wendt, Collette Dinnigan, Nicola Kidman, Deborah Lee Furness and Layne Beachley.
Other nominees for the Science & Environment category were Kirsty Albion and Lucy Manne (Co-Directors Australian Youth Climate Coalition) and Mara Bún (Founder of Green Cross Australia).
Dr Long is a principal investigator in clinical trials of drugs given to patients with early stage melanoma as well as patients with stage four melanoma at MIA. It is through work like this that a “penicillin moment” is emerging in the field of cancer.
“For the first time we are showing that you can harness the immune system to kill cancer cells,” Dr Long explains.
Dr Long was presented with the award at the InStyle event on Wednesday night.
“I know that life is short, I see that in my work, I want to make the most of every day,” said Dr Long in her acceptance speech.
One person still dies from melanoma every 6 hours in Australia and at MIA we are working hard to change this devastating statistic. With your support we can continue to find melanoma breakthroughs that result in life changing results for melanoma patients.
Help us reach our ultimate goal of finding a cure. Donate now.
“I had a complete response within about six months. All of my tumours disappeared."
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.
Melanoma March events have been cancelled. A Virtual March will be held on Sunday 29th March. Read this statement from MIA CEO Matthew Browne.
Thank you to the thousands of Aussies who bought ‘Game On Mole‘ t-shirts, took selfies, shared t-shirt pics on social media and started lifesaving conversations around sun safety and skin health.
Melanoma patients now have greater access to subsidised immunotherapy thanks to additional treatments today being listed on the PBS.
Brisbane couple Leon and Tamra Betts were, like thousands of others around Australia, on the couch watching MAFS when newlywed Natasha ran through her weekly beauty routine. When they heard the 26-year-old mention solarium use, they were shocked, and then saddened, prompting this open letter to all young Australians.
Professor Richard Scolyer, Co-Medical Director of Melanoma Institute Australia, will welcome international attendees this weekend to a sold-out, two-day course on ‘Pigmented Lesions and Other Hot Topics in Dermatopathology’.
It is time for a reality check on solariums.
They have no place in anyone’s beauty routine.
Throughout January our community created, hosted and participated in some amazing events, each of them helping us on our quest to reach zero deaths from melanoma.
Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.
Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.
Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.